Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: the phase II randomized controlled PROSPER trial
The perioperative period is characterized by psychological stress and inflammatory reactions that can contribute to disease recurrence or metastatic spread. These reactions are mediated particularly by catecholamines and prostaglandins. The PROSPER trial aimed to evaluate whether a perioperative dru...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , |
|---|---|
| Natura: | Article (Journal) |
| Lingua: | inglese |
| Pubblicazione: |
22 May 2025
|
| In: |
Langenbeck's archives of surgery
Year: 2025, Volume: 410, Fascicolo: 1, Pages: 1-12 |
| ISSN: | 1435-2451 |
| DOI: | 10.1007/s00423-025-03735-3 |
| Accesso online: | Resolving-System, kostenfrei, Volltext: https://doi.org/10.1007/s00423-025-03735-3 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00423-025-03735-3 |
| Note sull'autore: | Felix J. Hüttner, Rosa Klotz, Nathalia A. Giese, Bo Kong, Azaz Ahmed, Daniela Merz, Alexandra Pöchmann, Ina Burghaus, Thilo Hackert, Oliver Strobel, André L. Mihaljevic, Christoph W. Michalski, Markus W. Büchler, Markus K. Diener |
| Riassunto: | The perioperative period is characterized by psychological stress and inflammatory reactions that can contribute to disease recurrence or metastatic spread. These reactions are mediated particularly by catecholamines and prostaglandins. The PROSPER trial aimed to evaluate whether a perioperative drug repurposing with a non-selective betablocker (propranolol) and a COX-2 inhibitor (etodolac) is feasible and safe in the setting of pancreatic cancer surgery. |
|---|---|
| Descrizione del documento: | Gesehen am 15.07.2026 |
| Descrizione fisica: | Online Resource |
| ISSN: | 1435-2451 |
| DOI: | 10.1007/s00423-025-03735-3 |